| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 414 | 380 | 434 | 332 | | Cost of Revenue | 179 | 202 | 152 | 191 | | | Gross Profit | 236 | 178 | 282 | 141 | | | Operating Expenses | | Research Development | 668 | 671 | 595 | 567 | | Selling General and Administrative | 815 | 853 | 801 | 1,067 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,247) | (1,346) | (1,114) | (1,492) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,812 | 8,037 | (236) | 3,328 | | Earnings Before Interest And Taxes | 2,565 | 6,691 | (1,351) | 1,836 | | Interest Expense | (134) | 66 | 68 | 107 | | Income Before Tax | 2,699 | 6,625 | (1,419) | 1,729 | | Income Tax Expense | 73 | 386 | 125 | 1,833 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,626 | 6,239 | (1,543) | (104) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,695) | 6,239 | (1,543) | (104) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,695) | $6,239 | ($1,543) | ($104) |
|
0.56% Nasdaq 
Income Statement
